Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,086 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Highly porous nature of a primitive asteroid revealed by thermal imaging.
Okada T, Fukuhara T, Tanaka S, Taguchi M, Arai T, Senshu H, Sakatani N, Shimaki Y, Demura H, Ogawa Y, Suko K, Sekiguchi T, Kouyama T, Takita J, Matsunaga T, Imamura T, Wada T, Hasegawa S, Helbert J, Müller TG, Hagermann A, Biele J, Grott M, Hamm M, Delbo M, Hirata N, Hirata N, Yamamoto Y, Sugita S, Namiki N, Kitazato K, Arakawa M, Tachibana S, Ikeda H, Ishiguro M, Wada K, Honda C, Honda R, Ishihara Y, Matsumoto K, Matsuoka M, Michikami T, Miura A, Morota T, Noda H, Noguchi R, Ogawa K, Shirai K, Tatsumi E, Yabuta H, Yokota Y, Yamada M, Abe M, Hayakawa M, Iwata T, Ozaki M, Yano H, Hosoda S, Mori O, Sawada H, Shimada T, Takeuchi H, Tsukizaki R, Fujii A, Hirose C, Kikuchi S, Mimasu Y, Ogawa N, Ono G, Takahashi T, Takei Y, Yamaguchi T, Yoshikawa K, Terui F, Saiki T, Nakazawa S, Yoshikawa M, Watanabe S, Tsuda Y. Okada T, et al. Among authors: arai t. Nature. 2020 Mar;579(7800):518-522. doi: 10.1038/s41586-020-2102-6. Epub 2020 Mar 16. Nature. 2020. PMID: 32214245
Incidence and Predictors of Esophagogastric Varices Bleeding in Patients with Hepatocellular Carcinoma in Lenvatinib.
Iavarone M, Alimenti E, Tada T, Shimose S, Suda G, Yoo C, Soldà C, Piscaglia F, Tosetti G, Marra F, Vivaldi C, Conti F, Schirripa M, Iwamoto H, Sho T, Lee SH, Rizzato MD, Tonnini M, Rimini M, Campani C, Masi G, Foschi F, Bruccoleri M, Kawaguchi T, Kumada T, Hiraoka A, Atsukawa M, Fukunishi S, Ishikawa T, Tajiri K, Ochi H, Yasuda S, Toyoda H, Hatanaka T, Kakizaki S, Kawata K, Tada F, Ohama H, Itokawa N, Okubo T, Arai T, Imai M, Naganuma A, Casadei-Gardini A, Lampertico P. Iavarone M, et al. Among authors: arai t. Liver Cancer. 2023 Sep 14;13(2):215-226. doi: 10.1159/000534127. eCollection 2024 Apr. Liver Cancer. 2023. PMID: 38751557 Free PMC article.
The DESTINY+ Dust Analyser - a dust telescope for analysing cosmic dust dynamics and composition.
Simolka J, Blanco R, Ingerl S, Krüger H, Sommer M, Srama R, Strack H, Wagner C, Arai T, Bauer M, Fröhlich P, Gläser J, Gräßlin M, Henselowsky C, Hillier J, Hirai T, Ito M, Kempf S, Khawaja N, Kimura H, Klinkner S, Kobayashi M, Lengowski M, Li Y, Mocker A, Moragas-Klostermeyer G, Postberg F, Rieth F, Sasaki S, Schmidt J, Sterken V, Sternovsky Z, Strub P, Szalay J, Trieloff M, Yabuta H. Simolka J, et al. Among authors: arai t. Philos Trans A Math Phys Eng Sci. 2024 Jun 9;382(2273):20230199. doi: 10.1098/rsta.2023.0199. Epub 2024 May 13. Philos Trans A Math Phys Eng Sci. 2024. PMID: 38736332
ALBI score predicts morphological changes in esophageal varices following direct-acting antiviral-induced sustained virological response in patients with liver cirrhosis.
Atsukawa M, Tsubota A, Kondo C, Toyoda H, Takaguchi K, Nakamuta M, Watanabe T, Morishita A, Tani J, Okubo H, Hiraoka A, Nozaki A, Chuma M, Kawata K, Uojima H, Ogawa C, Asano T, Mikami S, Kato K, Matsuura K, Ikegami T, Ishikawa T, Tsuji K, Tada T, Tsutsui A, Senoh T, Kitamura M, Okubo T, Arai T, Kohjima M, Morita K, Akahane T, Nishikawa H, Iwasa M, Tanaka Y, Iwakiri K. Atsukawa M, et al. Among authors: arai t. J Gastroenterol. 2024 May 10. doi: 10.1007/s00535-024-02109-8. Online ahead of print. J Gastroenterol. 2024. PMID: 38727822
Outcomes of patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab in real-world clinical practice who met or did not meet the inclusion criteria for the phase 3 IMbrave150 trial.
Tada T, Kumada T, Hiraoka A, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Nishikawa H, Tsuji K, Ishikawa T, Tajiri K, Koshiyama Y, Toyoda H, Ogawa C, Hatanaka T, Kakizaki S, Kawata K, Ohama H, Tada F, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Nishimura T, Imai M, Kosaka H, Naganuma A, Matono T, Aoki T, Kuroda H, Yata Y, Koizumi Y, Nakamura S, Enomoto H, Kaibori M, Hiasa Y, Kudo M; Real‐life Practice Experts for HCC (RELPEC) Study Group; Hepatocellular Carcinoma Experts from 48 clinics in Japan (HCC 48) Group. Tada T, et al. Among authors: arai t. Aliment Pharmacol Ther. 2024 May 8. doi: 10.1111/apt.18037. Online ahead of print. Aliment Pharmacol Ther. 2024. PMID: 38716823
4,086 results